Gastrointestinal Symptoms Partnering 2009-2014

  • November 2014
  • -
  • Currentpartnering
  • -
  • 100 pages

The Gastrointestinal Symptoms Partnering 2009-2014 report provides understanding and access to the gastrointestinal symptoms partnering deals and agreements entered into by the worlds leading healthcare companies.

-Trends in gastrointestinal symptoms partnering deals
-Top gastrointestinal symptoms deals by value
-Deals listed by company A-Z, industry sector, stage of development, technology type

The Gastrointestinal Symptoms Partnering 2009-2014 provides understanding and access to the gastrointestinal symptoms partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides an analysis of gastrointestinal symptoms partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors gastrointestinal symptoms technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.

This data driven report contains over 100 links to online copies of actual gastrointestinal symptoms deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

The initial chapters of this report provide an orientation of gastrointestinal symptoms partnering trends.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in gastrointestinal symptoms partnering since 2009, including a summary of deals by industry sector, stage of development, deal type, and technology type. Numerous tables provide outline financial trends.

Chapter 3 provides an overview of the leading gastrointestinal symptoms deals since 2009. Deals are listed by headline value, signed by bigpharma, most active bigpharma. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 4 provides a comprehensive directory of gastrointestinal symptoms partnering deals signed and announced since 2009. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of gastrointestinal symptoms technologies and products.

Report scope

Gastrointestinal Symptoms Partnering 2009-2014 is intended to provide the reader with an in-depth understanding and access to gastrointestinal symptoms trends and structure of deals entered into by leading companies worldwide.

This data driven report includes:

-Trends in gastrointestinal symptoms dealmaking in the biopharma industry since 2009
-Access to summary headline, upfront, milestone and royalty data
-Access to over 100 gastrointestinal symptoms contract documents
-The leading gastrointestinal symptoms deals by value since 2009

In Gastrointestinal Symptoms Partnering 2009-2014, the available deals are listed by:

-Headline value
-Upfront payment value
-Royalty rate value
-Company A-Z
-Industry sector
-Stage of development at signing
-Deal component type
-Technology type

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Table Of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in gastrointestinal symptoms partnering

2.1. Introduction
2.2. Gastrointestinal symptoms partnering over the years
2.3. Big pharma gastrointestinal symptoms dealmaking activity
2.4. Big biotech gastrointestinal symptoms dealmaking activity
2.5. Most active gastrointestinal symptoms dealmakers
2.6. Gastrointestinal symptoms partnering by deal type
2.7. Gastrointestinal symptoms partnering industry sector
2.8. Gastrointestinal symptoms partnering by stage of development
2.9. Gastrointestinal symptoms partnering by technology type
2.10. Disclosed financial deal terms for gastrointestinal symptoms
2.10.1 Gastrointestinal symptoms headline values
2.10.2 Gastrointestinal symptoms upfront payments
2.10.3 Gastrointestinal symptoms milestone payments
2.10.4 Gastrointestinal symptoms royalty rates

Chapter 3 - Leading gastrointestinal symptoms deals

3.1. Introduction
3.2. Top gastrointestinal symptoms deals by value

Chapter 4 - Dealmaking directory

4.1. Introduction
4.2. Company A-Z
4.3. By deal type
4.4. By industry sector
4.5. By stage of development
4.6. By technology type

Chapter 5 - Partnering resource center

5.1. Online partnering
5.2. Partnering events
5.3. Further reading on dealmaking

Appendices

Appendix 1 - Deal type definitions

About Wildwood Ventures

Current Partnering
Current Agreements
Recent report titles from Current Partnering
Order Form - Reports
Order Form - Subscription Access Products

Table of figures

Figure 1: Gastrointestinal symptoms partnering since 2009
Figure 2: Big pharma - top 50 - gastrointestinal symptoms deals 2009 to 2014
Figure 3: Big pharma gastrointestinal symptoms deal frequency - 2009 to 2014
Figure 4: Big biotech - top 50 - gastrointestinal symptoms deals 2009 to 2014
Figure 5: Big biotech gastrointestinal symptoms deal frequency - 2009 to 2014
Figure 6: Gastrointestinal symptoms dealmaking activity- 2009 to 2014
Figure 7: Gastrointestinal symptoms partnering by deal type since 2009
Figure 8: Gastrointestinal symptoms partnering by industry sector since 2009
Figure 9: Gastrointestinal symptoms partnering by stage of development since 2009
Figure 10: Gastrointestinal symptoms partnering by technology type since 2009
Figure 11: Gastrointestinal symptoms deals with a headline value
Figure 12: Gastrointestinal symptoms deals with upfront payment values
Figure 13: Gastrointestinal symptoms deals with milestone payments
Figure 14: Gastrointestinal symptoms deals with royalty rates, %
Figure 15: Top gastrointestinal symptoms deals by value since 2009
Figure 16: Online partnering resources
Figure 17: Forthcoming partnering events
Figure 18: Deal type definitions

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Strategic Analysis of Women as Customers in the Global Car Industry : Companies Tailor Models for the Largest, Most Influential Future Buyer

Strategic Analysis of Women as Customers in the Global Car Industry : Companies Tailor Models for the Largest, Most Influential Future Buyer

  • $ 10 000
  • Industry report
  • October 2014
  • by Frost & Sullivan

Key Findings - Women are set to form a larger and more influential consumer segment than men, driving OEMs to launch specific models targeting women. - In 2012, the gender balance tipped with women comprising ...

Turbocharger Market by Vehicle Type (Passenger Car, LCV & HCV), Fuel Type (Diesel & Gasoline), Technology (VGT/VNT, Wastegate & Twin-Turbo), & Region - Industry Trends & Forecasts to 2019

Turbocharger Market by Vehicle Type (Passenger Car, LCV & HCV), Fuel Type (Diesel & Gasoline), Technology (VGT/VNT, Wastegate & Twin-Turbo), & Region - Industry Trends & Forecasts to 2019

  • $ 4 650
  • Industry report
  • August 2014
  • by MarketsandMarkets

The biggest challenge faced by the global automotive industry is meeting the regulations and standards set regarding the emissions of exhaust gases such as Carbon Dioxide (CO2), Nitrous Oxide (NOx) and ...

Automotive Airbag and Seat Belt Market for Passenger Cars - A Global Analysis: by Geography - Trends and Forecasts 2014 - 2019

Automotive Airbag and Seat Belt Market for Passenger Cars - A Global Analysis: by Geography - Trends and Forecasts 2014 - 2019

  • $ 4 650
  • Industry report
  • August 2014
  • by MarketsandMarkets

The major driving the demand of automotive airbag and seatbelt are stringent safety norms, increased safety awareness, technological advancement, affordability as well as institutions such as the New Ca ...

Pain Partnering 2009-2014

November 2014 $ 1 995

10 Companies

Company Profiles


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.